215 related articles for article (PubMed ID: 14737089)
1. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.
Ogawa H; Yin DP; Galili U
Gene Ther; 2004 Feb; 11(3):292-301. PubMed ID: 14737089
[TBL] [Abstract][Full Text] [Related]
2. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
3. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance.
Ogawa H; Mohiuddin MM; Yin DP; Shen J; Chong AS; Galili U
Transplantation; 2004 Feb; 77(3):366-73. PubMed ID: 14966409
[TBL] [Abstract][Full Text] [Related]
4. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
[TBL] [Abstract][Full Text] [Related]
6. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
Mohiuddin MM; Ogawa H; Yin DP; Galili U
Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
[TBL] [Abstract][Full Text] [Related]
7. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
8. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen.
Ogawa H; Yin DP; Shen J; Galili U
Blood; 2003 Mar; 101(6):2318-20. PubMed ID: 12406874
[TBL] [Abstract][Full Text] [Related]
10. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
11. Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.
Unfer RC; Hellrung D; Link CJ
Cancer Res; 2003 Mar; 63(5):987-93. PubMed ID: 12615713
[TBL] [Abstract][Full Text] [Related]
12. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
13. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase.
LaTemple DC; Galili U
Xenotransplantation; 1998 Aug; 5(3):191-6. PubMed ID: 9741457
[TBL] [Abstract][Full Text] [Related]
14. Expression changes in tolerant murine cardiac allografts after gene therapy with a lentiviral vector expressing alpha1,3 galactosyltransferase.
Evans JM; Doki T; Fischer-Lougheed J; Davicioni E; Kearns-Jonker M
Transplant Proc; 2006 Dec; 38(10):3172-80. PubMed ID: 17175215
[TBL] [Abstract][Full Text] [Related]
15. The bacterial flora of alpha-Gal knockout mice express the alpha-Gal epitope comparable to wild type mice.
Dahl K; Kirkeby S; d'Apice AF; Mathiassen S; Hansen AK
Transpl Immunol; 2005 Mar; 14(1):9-16. PubMed ID: 15814276
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA.
Deriy L; Chen ZC; Gao GP; Galili U
Glycobiology; 2002 Feb; 12(2):135-44. PubMed ID: 11886847
[TBL] [Abstract][Full Text] [Related]
17. Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies.
Galili U
Front Mol Biosci; 2023; 10():1209974. PubMed ID: 37449060
[TBL] [Abstract][Full Text] [Related]
18. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
19. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
20. The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway.
Igarashi Y; Onoe T; Ohdan H
Transplantation; 2015 Nov; 99(11):2325-36. PubMed ID: 26247556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
